Canadian Recommendations for Management of RA
The CRA has developed NEW 2011/2012 recommendations for the pharmacological management of RA that take into consideration Canada’s current healthcare system. The recommendations address treatment questions identified from a national needs assessment survey of Canadian rheumatology professionals and are published in 2 parts.
Highlights from the NEW 2011/ 2012 CRA Recommendations for RA
Part 1: RA Treatment Recommendations
- 5 overarching RA care principles
- 26 treatment recommendations addressing general RA treatment strategies as well as specific treatment strategies for the use of glucocorticoids and traditional and biologic DMARDs
- Summary RA assessment and treatment algorithms
Part 2: RA Safety Recommendation
13 recommendations addressing specific safety aspects of treatment with traditional and biologic DMARDs, including:
- Perioperative management
- Screening for latent tuberculosis infection (LTBI) and indications for initiating TB prophylaxis
- Optimal vaccination practices (which vaccines are indicated in patients with RA)
- Management of patients with malignancy (active and past)
Recommendations grouped in to user-friendly tables/checklists.
Journal of Rheumatology Publications
Editorial overview of 2011/2012 CRA Recommendation for RA
Part 1: 2011/2012 CRA Treatment Recommendations for RA
Part 2: 2011/2012 CRA Safety Recommendations for RA
Pre-Guideline National Needs Assessment Results
2011/2012 RA Treatment & Assessment Algorithms
2011/2012 CRA Recommendations for RA Part 1 Treatment
2012_CRA Recommendations for RA_Part 2 Safety
Questions and/or comments about these recommendations can be sent to firstname.lastname@example.org.